PETER W. RODINO, III, ESQ.

Corporate Board Profile

Tech Score: 0/100

AIM ImmunoTech Inc.

Filing Date	Source Excerpt
2013-09-16	Effective July 23, 2013, the Board of Directors approved the appointment of Peter W. Rodino III, Esq. as a Director of the Company to serve out the term of Mr. Piani until the Company's next annual meeting of stockholders. Mr. Rodino was also appointed to serve as a member of the Compensation Committee for the duration of this term. ... On July 23, 2013 by unanimous vote, the Corporate Governance and Nomination Committee recommended to the full Board of Directors that Mr. Rodino be appointed as a Director to the Board of Directors to replace Mr. Piani as a Director and Member of all Committees, and to designate Mr. Rodino as the Financial Expert and Chair of Audit Committee. ... On July 23, 2013, pursuant to its authority under its Amended and Restated Bylaws and the Delaware General Corporation Law, the Board created a Special Litigation Committee of the Board of Directors for which Peter Rodino, III, Esq. and Dr. Iraj E. Kiani were appointed as Members. ... Director Compensation - 2012 ... Peter W. Rodino, III was appointed to the Board on July 23, 2013 and beneficially owns 150,000 shares issuable upon exercise of options. No compensation for 2012 was reported.

Filing Date

Source Excerpt

2013-09-16

Effective July 23, 2013, the Board of Directors approved the appointment of Peter W. Rodino III, Esq. as a Director of the Company to serve out the term of Mr. Piani until the Company's next annual meeting of stockholders. Mr. Rodino was also appointed to serve as a member of the Compensation Committee for the duration of this term. ... On July 23, 2013 by unanimous vote, the Corporate Governance and Nomination Committee recommended to the full Board of Directors that Mr. Rodino be appointed as a Director to the Board of Directors to replace Mr. Piani as a Director and Member of all Committees, and to designate Mr. Rodino as the Financial Expert and Chair of Audit Committee. ... On July 23, 2013, pursuant to its authority under its Amended and Restated Bylaws and the Delaware General Corporation Law, the Board created a Special Litigation Committee of the Board of Directors for which Peter Rodino, III, Esq. and Dr. Iraj E. Kiani were appointed as Members. ... Director Compensation - 2012 ... Peter W. Rodino, III was appointed to the Board on July 23, 2013 and beneficially owns 150,000 shares issuable upon exercise of options. No compensation for 2012 was reported.

Data sourced from SEC filings. Last updated: 2026-02-03